For the treatment of serious bacterial infections caused by susceptible strains of beta-lactamase producing organisms in the following conditions: Lower respiratory tract infections; complicated and uncomplicated urinary tract infections; intra-abdominal infections; skin and structure infections; bacterial septicemia; gynecological infections.